BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33408226)

  • 1. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of
    van Doorn CLR; Schouten GK; van Veen S; Walburg KV; Esselink JJ; Heemskerk MT; Vrieling F; Ottenhoff THM
    Front Immunol; 2021; 12():739938. PubMed ID: 34552598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
    Ho N; Coomber BL
    Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α.
    Škorja Milić N; Dolinar K; Miš K; Matkovič U; Bizjak M; Pavlin M; Podbregar M; Pirkmajer S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of two aspects of metabolism in breast cancer treatment.
    Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
    Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.
    Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N
    J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Sodium Dichloroacetate on Mitochondrial Dysfunction and Neuronal Death Following Hypoglycemia-Induced Injury.
    Kho AR; Choi BY; Lee SH; Hong DK; Jeong JH; Kang BS; Kang DH; Park KH; Park JB; Suh SW
    Cells; 2019 May; 8(5):. PubMed ID: 31052436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.
    Tiersma JF; Evers B; Bakker BM; Jalving M; de Jong S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
    Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
    Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
    BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming Energy Metabolism with Synthesized PDK Inhibitors Based on Dichloroacetate Derivatives and Targeted Delivery Systems for Enhanced Cancer Therapy.
    She W; Liu T; Li H; Wang Z; Guo Z; Liu Y; Liu Y
    J Med Chem; 2023 Nov; 66(21):14683-14699. PubMed ID: 37688544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells.
    de Mey S; Dufait I; Jiang H; Corbet C; Wang H; Van De Gucht M; Kerkhove L; Law KL; Vandenplas H; Gevaert T; Feron O; De Ridder M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33316932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy.
    Wei G; Sun J; Luan W; Hou Z; Wang S; Cui S; Cheng M; Liu Y
    J Med Chem; 2019 Oct; 62(19):8760-8772. PubMed ID: 31509699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis.
    Al-Azawi A; Sulaiman S; Arafat K; Yasin J; Nemmar A; Attoub S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
    Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
    Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.
    Kim TS; Lee M; Park M; Kim SY; Shim MS; Lee CY; Choi DH; Cho Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
    Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P
    Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.